Oruka Therapeutics, Inc.
$68.87
▲
5.71%
2026-04-21 08:41:00
orukatx.com
NGM: ORKA
Explore Oruka Therapeutics, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.48 B
Current Price
$68.87
52W High / Low
$70.5 / $8.36
Stock P/E
—
Book Value
$9.63
Dividend Yield
—
ROCE
-25.79%
ROE
-24.69%
Face Value
—
EPS
$-1.85
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
68
Beta
—
Debt / Equity
0.41
Current Ratio
22.37
Quick Ratio
22.37
Forward P/E
-23.46
Price / Sales
—
Enterprise Value
$2.62 B
EV / EBITDA
-21.48
EV / Revenue
—
Rating
Strong Buy
Target Price
$72.17
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Relmada Therapeutics, Inc. | $7.37 | — | $773.03 M | — | -67.49% | -25.62% | $7.94 / $0.27 | $1.18 |
| 2. | AgomAb Therapeutics NV | $10.79 | — | $0.28 M | — | -24.35% | -27.25% | $17.45 / $9 | $-7,123.4 |
| 3. | eXoZymes, Inc. | $10.66 | — | $89.88 M | — | -220.6% | -1.33% | $18.4 / $7.08 | $0.4 |
| 4. | iBio, Inc. | $1.97 | — | $70.3 M | — | -108.92% | -70.22% | $3.82 / $0.56 | $1.88 |
| 5. | Bio-Techne Corporation | $59.22 | 116.91 | $9.33 B | 0.53% | 10.19% | 3.97% | $72.16 / $46.01 | $12.9 |
| 6. | TuHURA Biosciences, Inc. | $2.83 | — | $179.93 M | 0% | -120.19% | -1.69% | $4.44 / $0.41 | $0.35 |
| 7. | ProMIS Neurosciences, Inc. | $11.45 | — | $24.63 M | — | 3267.2% | -5.22% | $39.75 / $6.27 | $-0.58 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -34.43 M | -34.1 M | -28.43 M | -25.09 M | -29.45 M |
| Net Profit | -29.58 M | -30.28 M | -24.57 M | -21 M | -28.62 M |
| EPS in Rs | -0.6 | -0.61 | -0.5 | -0.42 | -0.58 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | |
|---|---|---|
| Sales | 0 M | — |
| Operating Profit | -122.05 M | — |
| Net Profit | -105.43 M | — |
| EPS in Rs | -2.13 | — |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | |
|---|---|---|
| Total Assets | 488.62 M | 396.02 M |
| Total Liabilities | 19.62 M | 16.73 M |
| Equity | 469 M | 379.29 M |
| Current Assets | 343.86 M | 376.87 M |
| Current Liabilities | 15.37 M | 13.04 M |
Cash Flow
Last available yearly cash flow history
| 2025 | |
|---|---|
| Operating CF | -88.21 M |
| Investing CF | -96.75 M |
| Financing CF | 170.31 M |
| Free CF | -88.42 M |
| Capex | -0.21 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | |
|---|---|
| Revenue Growth % | — |
| Earnings Growth % | — |
| Profit Margin % | — |
| Operating Margin % | — |
| Gross Margin % | — |
| EBITDA Margin % | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2024-08-29 | $19.356 |
Stock Splits
| Date | Split |
|---|---|
| 2024-09-03 | 1:0.0833333 |